AI-driven dermatology platform Cureskin has netted $20 million in a Sequence B funding spherical led by HealthQuad. The spherical was additionally participated by JSW Ventures, Khosla Ventures, and Sharrp Ventures.
“These funds will assist additional improve our AI capabilities, speed up our development, and develop answer choices,” mentioned co-founder and CEO Guna Kakulapati in an announcement.
Cureskin beforehand raised $5 million in Sequence A funding. To this point, it claims to have handled about 1.5 million prospects for numerous pores and skin circumstances by means of its app. It notes that over 80% of them are from tier 2 and three cities.
Diabetes-focused well being tech startup Sugar.match has obtained a further $5 million in Sequence A funding from B Capital.
This brings its whole Sequence A funding, the primary spherical of which occurred in November, to $16 million.
In an announcement, the corporate mentioned it can use its further funds to develop its choices, enhance its presence, and hasten R&D in diabetes administration.
Since launching by end-2021, Sugar.match has now served over 30,000 customers on its platform, providing a personalised, complete program for managing diabetes that leverages steady glucose monitoring expertise and knowledge. It has additionally just lately began working diabetes clinics in Bangalore, which supply a variety of companies similar to stress therapies, dwell health and yoga periods, and VR chromotherapy.
Diagnostic service supplier Cardiotrack, a model of Uber Diagnostics, has obtained $2 million in a pre-Sequence A funding spherical led by Girish Narasimhan, angel investor and principal of a global funding banking agency.
This provides to the $1.6 million it raised beforehand from a cohort of high-net-worth people. It has not disclosed the place and the way it will use its recent funds.
Cardiotrack, which affords telemedicine kits, medical-grade and IoT diagnostic gadgets, and knowledge analytics options, serves a few of India’s largest well being and life insurers and community of diagnostic centres in over 300 places.